Effect of denosumab versus zoledronic acid on health-related quality of life in patients with metastatic breast cancer.
L. Fallowfield
Consultant or Advisory Role - Amgen
Honoraria - Amgen
D. Patrick
Consultant or Advisory Role - Amgen
J. Body
Consultant or Advisory Role - Amgen; Novartis
Honoraria - Amgen; Novartis
Research Funding - Amgen
A. Lipton
Consultant or Advisory Role - Amgen; Novartis
Honoraria - Amgen; Novartis
Research Funding - Novartis
Expert Testimony - Novartis
K. S. Tonkin
No relevant relationships to disclose
Y. Qian
Employment or Leadership Position - Amgen
Consultant or Advisory Role - Amgen
Stock Ownership - Amgen
Honoraria - Amgen
Q. Jiang
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
A. H. Braun
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Research Funding - Amgen
R. D. Dansey
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Research Funding - Amgen
K. Chung
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Research Funding - Amgen